There were numerous articles in March 2018 that covered a wide range of topical issues. Here are five of the best stories you might have missed… (Click the headline to finish reading the story)

The Press for Progress: Charting the Role of Women in the Life Sciences Industry

On International Women’s Day, Shahana Chowdhury explores the role of women within the life sciences industry

International Women’s Day (IWD) is a global day celebrating the social, economic, cultural and political achievements of women. IWD has occurred annually for over a century and this year Clinical Trials Arena would like to pay tribute to women in the pharmaceutical, biotech and medical device industries.

Smarter Clinical Trials are Possible by Leveraging Mobile Health Technologies

The consumer mobile health technology revolution has dramatically altered the way we view health care. Personal health tracking apps and wearables provide real-time and continuous data to the user, allowing them to understand, track, and trend everything from heart rate to blood pressure, from cognitive function to memory, and everything in between. Caregivers can even be notified in the event troubling data is received. The revolution doesn’t just stop there, though. Sensors don’t just provide data on users; they are also embedded in everything from cars to consumer packaging, giving real-time data on surroundings, informing on viability of product, or any of a host of other data points. Finally, tools like telemedicine can provide on-demand knowledge of a medical professional with the convenience of at-home care.

Home-Based Clinical Studies – A Paradigm Shift?

While patient recruitment and retention are central to the success of clinical trials, achieving this can be difficult. These challenges, along with ensuring protocol compliance, directly influence overall study costs, results, and timelines.

Patient participation in a clinical study can confer significant difficulties to study patients due to the frequency of visits, travel to the study sites, long visit times, disruption in their schedules and activities, and finally, geographic exclusion from distant sites.

Improve Performance and Ensure Better Planning with Clinical Supply Portfolio-level Visualization

Visualizing your clinical trial supply forecasts at portfolio-level helps strategic and operational decision-making. By intuitively interacting with your optimized data at this level, you have a clear overview of your portfolio and can immediately identify areas of improvement.

Using an advanced optimization tool for clinical trial supply management, combined with business intelligence dashboards, such as the N-SIDE Solution CT-FAST, enables portfolio-level measures to be visualized on demand. By using CT-FAST, there is a standardized process for collecting and approving assumptions for inputs, as well as for forecasting, and reporting, so there is assurance the same types of information can be compared across studies.

Overcoming Operational Barriers to Implementing eCOA in a Clinical Trial

Sponsors are increasingly turning to electronic solutions in order to solve the operational challenges that are faced when implementing clinical trials. One of the fastest growing solutions focuses on the implementation of electronic clinical outcome assessments (eCOAs) to help collect trial data. This article will walk through some of the primary operational barriers facing any organization when considering the use of eCOAs in a clinical trial setting. We’ll also discuss how to overcome those barriers to ensure that the eCOA system brings value and reliability to a study.


In case you missed the CTA Supply Chain Week, click here to read exclusive articles delving into the current issues and concerns involving the supply chain.